While it is a milestone event for any Bio-tech to start a new trial or move to the next stage of a trial due to the tight trial requirements the general market is only interested in results. " Boring " waiting time, hence the willingness of some to sell out of frustration and impatience which on the other hand opens up fantastic investment opportunities for the patient ones.
Considering the about $8m cash at hand, the pipeline, the NK success results and Brain cancer progress so far plus the CDH 17 to start the clinical trials soon - what an opportunity.
Will I get my 7.1c order first in line filled today or do I have to step up. Looked so promising with 500k placed at 7.2c but someone else seeing huge value here just took it out. Good on you buyer even though I missed out at this stage. Damn, another bargain hunter just emerged.
GLTA
CHM Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)